Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haim Belinson

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Journal of Alzheimer'S Disease : JAD|April 14, 2009
Pathological synergism between amyloid-beta and apolipoprotein E4--the most prevalent yet understudied genetic risk factor for Alzheimer's diseaseHaim Belinson, Daniel M Michaelson
Journal of Neural Transmission (Vienna, Austria : 1996)|April 17, 2009
ApoE4-dependent Abeta-mediated neurodegeneration is associated with inflammatory activation in the hippocampus but not the septumHaim Belinson, Daniel M Michaelson
Neurobiology of Aging|October 7, 2006
Neuron-specific susceptibility to apolipoprotein E4Haim Belinson, Iftach Dolev, Daniel M Michaelson
Neuro-Degenerative Diseases|March 7, 2008
Activation of the amyloid cascade by intracerebroventricular injection of the protease inhibitor phosphoramidonYotam Nisemblat, Haim Belinson, Iftach Dolev, et al.
Journal of Neurochemistry|August 2, 2007
Intraneuronal amyloid-beta plays a role in mediating the synergistic pathological effects of apoE4 and environmental stimulationOfir Levi, Iftach Dolev, Haim Belinson, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 2, 2008
Activation of the amyloid cascade in apolipoprotein E4 transgenic mice induces lysosomal activation and neurodegeneration resulting in marked cognitive deficitsHaim Belinson, Dimitri Lev, Eliezer Masliah, et al.
Neuro-Degenerative Diseases|February 18, 2010
Possible role of tau in mediating pathological effects of apoE4 in vivo prior to and following activation of the amyloid cascadeDafna Inbar, Haim Belinson, Hanna Rosenman, et al.
Journal of Alzheimer'S Disease : JAD|September 23, 2010
Following activation of the amyloid cascade, apolipoprotein E4 drives the in vivo oligomerization of amyloid-β resulting in neurodegenerationHaim Belinson, Zehavit Kariv-Inbal, Rakez Kayed, et al.
International Journal of Alzheimer'S Disease|February 26, 2011
ApoE4-Driven Accumulation of Intraneuronal Oligomerized Aβ42 following Activation of the Amyloid Cascade In Vivo Is Mediated by a Gain of FunctionLia Zepa, Moran Frenkel, Haim Belinson, et al.
Pain|September 26, 2024
Dual Kv7.2/3-TRPV1 modulators inhibit nociceptor hyperexcitability and alleviate pain without target-related side effectsAdi Raveh, Yefim Pen, Alon Silberman, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Journal of Alzheimer'S Disease : JAD|April 14, 2009
Pathological synergism between amyloid-beta and apolipoprotein E4--the most prevalent yet understudied genetic risk factor for Alzheimer's diseaseHaim Belinson, Daniel M Michaelson
Journal of Neural Transmission (Vienna, Austria : 1996)|April 17, 2009
ApoE4-dependent Abeta-mediated neurodegeneration is associated with inflammatory activation in the hippocampus but not the septumHaim Belinson, Daniel M Michaelson
Neurobiology of Aging|October 7, 2006
Neuron-specific susceptibility to apolipoprotein E4Haim Belinson, Iftach Dolev, Daniel M Michaelson
Neuro-Degenerative Diseases|March 7, 2008
Activation of the amyloid cascade by intracerebroventricular injection of the protease inhibitor phosphoramidonYotam Nisemblat, Haim Belinson, Iftach Dolev, et al.
Journal of Neurochemistry|August 2, 2007
Intraneuronal amyloid-beta plays a role in mediating the synergistic pathological effects of apoE4 and environmental stimulationOfir Levi, Iftach Dolev, Haim Belinson, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 2, 2008
Activation of the amyloid cascade in apolipoprotein E4 transgenic mice induces lysosomal activation and neurodegeneration resulting in marked cognitive deficitsHaim Belinson, Dimitri Lev, Eliezer Masliah, et al.
Neuro-Degenerative Diseases|February 18, 2010
Possible role of tau in mediating pathological effects of apoE4 in vivo prior to and following activation of the amyloid cascadeDafna Inbar, Haim Belinson, Hanna Rosenman, et al.
Journal of Alzheimer'S Disease : JAD|September 23, 2010
Following activation of the amyloid cascade, apolipoprotein E4 drives the in vivo oligomerization of amyloid-β resulting in neurodegenerationHaim Belinson, Zehavit Kariv-Inbal, Rakez Kayed, et al.
International Journal of Alzheimer'S Disease|February 26, 2011
ApoE4-Driven Accumulation of Intraneuronal Oligomerized Aβ42 following Activation of the Amyloid Cascade In Vivo Is Mediated by a Gain of FunctionLia Zepa, Moran Frenkel, Haim Belinson, et al.
Pain|September 26, 2024
Dual Kv7.2/3-TRPV1 modulators inhibit nociceptor hyperexcitability and alleviate pain without target-related side effectsAdi Raveh, Yefim Pen, Alon Silberman, et al.
Pageof 2